Clinical Trial Update: Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on allogeneic mitochondria (PN-101) transplantation for refractory polymyositis or dermatomyositis have completed Phase 1 and Phase 2 sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• PN-101

Snippet

Sponsor: Paean Biotechnology Inc. | Conditions: Polymyositis, Dermatomyositis | Phase 1, Phase 2 | Status: COMPLETED